Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy
Authors:
- 31 October 2024
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 149, 103327
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigensHepatology, 2014
- Follicles, germinal centers, and immune mechanisms in primary biliary cirrhosisHepatology, 2014
- CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosisHepatology, 2014
- Citrulline‐Specific Th1 Cells Are Increased in Rheumatoid Arthritis and Their Frequency Is Influenced by Disease Duration and TherapyArthritis & Rheumatology, 2014
- IL-12/Th1 and IL-23/Th17 Biliary Microenvironment in Primary Biliary Cirrhosis: Implications for TherapyHepatology, 2013
- Biochemical and Immunologic Effects of Rituximab in Patients With Primary Biliary Cirrhosis and an Incomplete Response to Ursodeoxycholic AcidHepatology, 2011
- Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitisHepatology, 2010
- HLA–DR1001 presents “altered‐self” peptides derived from joint‐associated proteins by accepting citrulline in three of its binding pocketsArthritis & Rheumatism, 2010
- Curing CNS autoimmune disease with myelin‐reactive Foxp3+ TregEuropean Journal of Immunology, 2009
- Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis†Hepatology, 2006